- â ð° 幎é5å ãã«è¶ ââäžçæå€§çŽã®å»çã·ã¹ãã ã®æ£äœ
- â¡ ð§Ÿ ã¢ã¡ãªã«äººã¯âäœåºŠãâå»çè²»ãæã£ãŠãã
- ⢠ð¬ð§ ã€ã®ãªã¹ã»ð©ðª ãã€ããšæ¯ã¹ããšäœãéãã®ã
- ⣠ð¯ðµ æ¥æ¬ã¯âäžéåâã ããäŸ¡æ Œçµ±å¶ãå¹ããŠãã
- †âïž ãªãã¢ã¡ãªã«ã¯åçŽãªå¶åºŠã«å€ããããªãã®ã
- â ãŸãšãïŒã¢ã¡ãªã«å»çã®åé¡ã¯ãé«ããã ãã§ãªããè€éããããããš
- ð åèã»åºå ž
â ð° 幎é5å ãã«è¶ ââäžçæå€§çŽã®å»çã·ã¹ãã ã®æ£äœ
ã¢ã¡ãªã«ã®å»çå¶åºŠã¯ãäžçã§ãçªåºããŠé«é¡ãªã·ã¹ãã ã§ãã2023幎ã®å»çæ¯åºã¯çŽ4.9å ãã«ã2024幎ã«ã¯çŽ5.3å ãã«ã«éããGDPã®18ïŒ ååŸãå ããèŠæš¡ã«ãªã£ãŠããŸããããã¯åã«ãå»çãé«ãããšãã話ã§ã¯ãªããçŽçšè ãéçšäž»ãå人ã»å®¶æãæ åå£äœãç ç©¶å©æãæ°éä¿éºãã¡ãã£ã±ã¢ãã¡ãã£ã±ã€ããç é¢ã補è¬äŒç€Ÿãå»çæ©åšäŒæ¥ãªã©ãç¡æ°ã®è³éã«ãŒãã絡ã¿åã巚倧ãªè³é埪ç°ã·ã¹ãã ã§ããã³ã©ã ãã¹ãã®ã¢ã³ããªã¥ãŒã»ãã¡ã³æ°ã¯ããã®è€éãªæ§é ããµã³ããŒã»ãã€ã¢ã°ã©ã ã§å¯èŠåããã¢ã¡ãªã«ç€ŸäŒãäœãäžãããå¿ãŸãããæªç©ããšè¡šçŸããŸããã

â¡ ð§Ÿ ã¢ã¡ãªã«äººã¯âäœåºŠãâå»çè²»ãæã£ãŠãã
ã¢ã¡ãªã«å»çã®å€§ããªç¹åŸŽã¯ãå人ãè€æ°ã®çµè·¯ã§å»çè²»ãè² æ ããŠããç¹ã§ããããšãã°äŒç€Ÿå¡ã¯ãæåŸçšã絊äžçšãéããŠå ¬çå»çå¶åºŠãæ¯ããããã«éçšäž»çµç±ã®æ°éä¿éºæã絊äžããè² æ ãã蚺çæã«ã¯èªå·±è² æ éãå 責é¡ãæ¯æããŸããã€ãŸããçšéã»ä¿éºæã»èªå·±è² æ ãéãªããæ¯æãæ§é ãéåžžã«èŠãã«ãããªã£ãŠããŸãã
ð äž»ãªè³éã®æµã
- ðïž çŽçšè ïŒã¡ãã£ã±ã¢ãã¡ãã£ã±ã€ããé圹è»äººå»çãªã©ãæ¯ãã
- ð¢ éçšäž»ïŒåŸæ¥å¡åãå¥åº·ä¿éºã®å€§éšåãè² æ
- ðšâð©âð§ å人ã»å®¶æïŒä¿éºæãèªå·±è² æ ãè¬ä»£ãæªä¿éºåãæ¯æã
- ð ä¿éºäŒç€Ÿã»ç é¢ã»è£œè¬äŒç€ŸïŒè€éãªè«æ±ã»äŸ¡æ Œäº€æžã»åéãè¡ã
ãã®ä»çµã¿ã§ã¯ãå»çãåããåãã倿¹åã«ãéãæµããå®éã«ç é¢ãžè¡ã£ãåŸã远å è²»çšãçºçããŸãããã®ãããåäžæ¯æè å¶åºŠãæã€åœãšæ¯ã¹ãŠã管çã³ã¹ããäŸ¡æ Œäº€æžã³ã¹ããèšãã¿ãããæ§é ã«ãªã£ãŠããŸãã

⢠ð¬ð§ ã€ã®ãªã¹ã»ð©ðª ãã€ããšæ¯ã¹ããšäœãéãã®ã
ã€ã®ãªã¹ã®NHSã¯ãå»çã¯çšéã§æ¯ããå©çšæã«ã¯ååç¡æããšããããŽã¡ãªããžã¢ãã«ã«åºã¥ããŠããŸãã2024幎ã®è±åœå»çæ¯åºã¯çŽ3170åãã³ãã§ããã®å€§éšåã¯æ¿åºè²¡æºããæ¯åºãããŠããŸããè³éã®å ¥å£ãçšéäžå¿ã®ãããã¢ã¡ãªã«ã®ããã«ä¿éºäŒç€Ÿã»éçšäž»ã»åäººè² æ ãè€éã«çµ¡ã¿åãæ§é ã§ã¯ãããŸãããäžæ¹ããã€ãã¯ãã¹ãã«ã¯ã¢ãã«ãšåŒã°ããéçšäž»ãšåŽåè ãä¿éºæãæ åºããè€æ°ã®çŸç é庫ãéããŠå»çè²»ãæ¯æãä»çµã¿ã§ããç«¶äºã¯ãããŸãããæ¿åºã«ããäŸ¡æ ŒèŠå¶ãšåœæ°çä¿éºããããããã¢ã¡ãªã«ã»ã©äŸ¡æ ŒãéæŸãã«ãªãã«ããã®ãç¹åŸŽã§ãã

⣠ð¯ðµ æ¥æ¬ã¯âäžéåâã ããäŸ¡æ Œçµ±å¶ãå¹ããŠãã
æ¥æ¬ã®å»çå¶åºŠã¯ããã€ãåã«è¿ã瀟äŒä¿éºæ¹åŒãæ¡çšãã€ã€ãçšéãšèªå·±è² æ ãçµã¿åããããã€ããªããåã§ããäŒç€Ÿå¡ã¯å¥åº·ä¿éºãèªå¶æ¥è ãéè·è ã¯åœæ°å¥åº·ä¿éºãé«éœ¢è ã¯åŸæé«éœ¢è å»çå¶åºŠã«å å ¥ããååãšããŠå šåœæ°ãå ¬çä¿éºã§ã«ããŒãããŸããæ£è ã¯å»çæ©é¢ã§1ã3å²ãè² æ ããŸããã蚺çå ±é ¬ãè¬äŸ¡ã¯åœã決ãããããåãæ²»çã§ç é¢ããšã«äŸ¡æ Œã倧ããå€ããããšã¯åºæ¬çã«ãããŸããããã®ãå šåœçµ±äžäŸ¡æ Œãããã¢ã¡ãªã«ãšã®å€§ããªéãã§ãã

ð ååœã¢ãã«ã®éã
- ðºðž ã¢ã¡ãªã«ïŒæ°éä¿éºã»å ¬çä¿éºã»èªå·±è² æ ãæ··åšããäŸ¡æ Œãè€é
- ð¬ð§ ã€ã®ãªã¹ïŒçšè²¡æºäžå¿ãNHSãå»çæäŸãæ ã
- ð©ðª ãã€ãïŒç€ŸäŒä¿éºäžå¿ãæ¿åºèŠå¶äžã§è€æ°ä¿éºè ãç«¶äº
- ð¯ðµ æ¥æ¬ïŒåœæ°çä¿éºïŒå ¬å®äŸ¡æ ŒïŒäžå®ã®èªå·±è² æ

†âïž ãªãã¢ã¡ãªã«ã¯åçŽãªå¶åºŠã«å€ããããªãã®ã
ã¢ã¡ãªã«ãã€ã®ãªã¹ããã€ãã®ãããªå¶åºŠãžç°¡åã«ç§»è¡ã§ããªãçç±ã¯ãæè¡çãªåé¡ãããæ¿æ²»çãªåé¡ã§ããåäžæ¯æè å¶åºŠãå°å ¥ããã«ã¯ãæ°éä¿éºäŒç€Ÿã®åœ¹å²çž®å°ãçšè² æ ã®åèšèšãç é¢ã»è£œè¬äŒç€Ÿã»éçšäž»ã»å·æ¿åºãšã®å©å®³èª¿æŽãå¿ èŠã«ãªããŸããããã«ã¢ã¡ãªã«ã§ã¯ãæ¿åºã®ä»å ¥ãã©ããŸã§èš±ããããå»çãæš©å©ãšèŠããåžå ŽãµãŒãã¹ãšèŠãããã«ã€ããŠåœæ°çåæã圢æããã«ãããå¶åºŠæ¹é©ã¯åžžã«æ¿æ²»å¯Ÿç«ã®äžå¿ã«ãªããŸããè¿å¹Žã¯ã¡ãã£ã±ã¢ã«ããè¬äŸ¡äº€æžãå§ãŸãã2026幎ããäžéšã®é«é¡å»è¬åã«äº€æžäŸ¡æ Œãé©çšããããªã©æ¹é©ãé²ãã§ããŸãããå»çå¶åºŠå šäœãåçŽåããã«ã¯ãŸã 倧ããªå£ããããŸãã
â ãŸãšãïŒã¢ã¡ãªã«å»çã®åé¡ã¯ãé«ããã ãã§ãªããè€éããããããš
ã¢ã¡ãªã«ã®å»çå¶åºŠã¯ã幎é5å ãã«èŠæš¡ãšããéé¡ã®å€§ããã ãã§ãªãããéã®æµããããŸãã«ãè€éã§ã誰ãäœã«ãããæã£ãŠããã®ããèŠãã«ããç¹ã«æ¬è³ªçãªåé¡ããããŸããã€ã®ãªã¹ããã€ããæ¥æ¬ãšæ¯èŒãããšãã¢ã¡ãªã«ã¯åžå Žç«¶äºãå ¬çæ¯æŽãéçšäž»ä¿éºãåäººè² æ ããã¹ãŠåæã«æ±ã蟌ãã å¶åºŠã§ããããã®çµæãšããŠé«ã³ã¹ãåãšäžéæåãé²ãã§ããŸããå»çè²»ãäžããã«ã¯ãåãªãå€äžãæ¿çã§ã¯ãªãããäœãå ¬çã«è² æ ããäœãåžå Žã«ä»»ããã©ãã«äŸ¡æ Œçµ±å¶ããããã®ãããšããæ ¹æ¬çãªèšèšã®èŠçŽããå¿ èŠã§ãã
ð åèã»åºå ž
- Andrew TsangãAn Abominable Creatureã
- Centers for Medicare & Medicaid ServicesãNational Health Expenditure Fact Sheetã
- Health AffairsãNational Health Expenditures In 2023ã
- OECDãHealth expenditure in relation to GDPã
- UK Office for National StatisticsãUK Health Accounts 2024ã
- CMSãMedicare Drug Price Negotiation Programã
